Skip to main content
Clinical Trials/IRCT20220424054643N1
IRCT20220424054643N1CompletedPhase 3

The effects of Colostrum and Whey protein supplementation on rate of union, wound healing, functional activity and C reactive protein in Pelvic and Femur fracture patients

Shahid Beheshti University of Medical Sciences0 sites340 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
340

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Willingness to cooperate and complete the informed consent form by the patient or legal guardian
  • Patients 18 to 65 years
  • Pelvic and hip fractures
  • Body mass index < 35 kg / m2
  • Candidate for pelvic and femoral fixation surgery
  • Active movement without assistance from 2 months before fracture

Exclusion Criteria

  • Need to other supplement due to a specific problem (kidney, lung, liver, etc.)
  • Have diabetes
  • Have Gastrointestinal diseases malabsorption
  • Have parathyroid gland disorders
  • Have hepatic encephalopathy and the liver cirrhosis
  • Have recent myocardial infarction
  • Have uncompensated congestive heart failure
  • Have lower limb amputation
  • Existence the symptoms of angina
  • Have Chest pain or dyspnea (including severe COPD)
  • Have kidney failure
  • Have metastatic cancer
  • Have infection and sepsis
  • Have uncontrolled blood pressure
  • Have cognitive impairment (3MS score> 73)
  • Take drugs that affect bone metabolism, such as calcitonin, bisphosphonates and corticosteroids
  • Take supplements or formulas to strengthen the immune system, including: arginine, glutamine, vitamins C and E, selenium, zinc or omega-3 fatty acids in the last 2 weeks before the intervention
  • Have allergy or lactose intolerance
  • Participate in other clinical trial studies at the same time as the present study

Investigators

Similar Trials